The correlation between dual colour chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene status

被引：0
|
作者：
Pedersen, Marianne [1 ]
Rasmussen, Birgitte Bruun [2 ]
机构：
[1] Roskilde Hosp, Dept Pathol, Roskilde, Denmark
[2] Hilleroed Hosp, Dept Pathol, Hillerod, Denmark
来源：
APMIS | 2008年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [41] Automated Silver-enhanced In Situ Hybridization for Evaluation of HER2 Gene Status in Breast Carcinoma: Comparison with Fluorescence In Situ Hybridization and Immunohistochemistry
    Sung, Woo Jung
    Park, Seok Ju
    Gu, Mi Jin
    Bae, Young Kyung
    [J]. KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 28 - 34
  • [42] The Comparison of Automated Silver in situ Hybridization and Fluorescence in situ Hybridization for Evaluating HER2 Gene Amplification in Breast Carcinoma
    Kim, Tae-Jung
    Kim, Tae Eun
    Jung, Eun Sun
    Yim, Hyeon Woo
    Song, Byung Joo
    Jung, Sang Seol
    Lee, Ahwon
    Choi, Yeong-Jin
    Lee, Kyo-Young
    [J]. JOURNAL OF BREAST CANCER, 2009, 12 (04) : 295 - 301
  • [43] Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in breast carcinoma
    Neagu, M.
    Butur, G.
    Ardeleanu, C.
    [J]. FEBS JOURNAL, 2012, 279 : 328 - 328
  • [44] Concordance of HER2 dual-color, dual-hapten in situ hybridization (DDISH) with fluorescence in situ hybridization on gastric carcinoma
    Loftin, I.
    Miller, R.
    McElhinny, A.
    Roche, P.
    Padilla, M.
    Ranger-Moore, J.
    Wu, P.
    [J]. VIRCHOWS ARCHIV, 2010, 457 (02) : 254 - 254
  • [45] HER2 Dual In Situ Hybridization Correlations and Cautions
    Troxell, Megan
    Sibley, Richard K.
    West, Robert B.
    Bean, Gregory R.
    Allison, Kimberly H.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (12) : 1525 - 1534
  • [46] Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in breast carcinoma
    Neagu, M.
    Ardeleanu, C.
    Butur, G.
    Florin, A.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S249 - S250
  • [47] Assessing HER2 Immunohistochemistry Using Digital Imaging Analysis and its Correlation with HER2 Fluorescence in Situ Hybridization Results
    Hartage, Ramon
    Yearsley, Kurtis
    Hammond, Scott
    Parwani, Anil
    Li, Zaibo
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [48] Assessing HER2 Immunohistochemistry Using Digital Imaging Analysis and its Correlation with HER2 Fluorescence in Situ Hybridization Results
    Hartage, Ramon
    Yearsley, Kurtis
    Hammond, Scott
    Parwani, Anil
    Li, Zaibo
    [J]. MODERN PATHOLOGY, 2019, 32
  • [49] Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens
    Daniele, Lorenzo
    Macri, Luigia
    Schena, Marina
    Dongiovanni, Diego
    Bonello, Lisa
    Armando, Enrico
    Ciuffreda, Libero
    Bertetto, Oscar
    Bussolati, Gianni
    Sapino, Anna
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) : 1223 - 1229
  • [50] In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry
    Kim, Min A.
    Jung, Jung Eun
    Lee, Hee Eun
    Yang, Han-Kwang
    Kim, Woo Ho
    [J]. HUMAN PATHOLOGY, 2013, 44 (04) : 487 - 494
12345